Inspection Record

MSS Ltd. — Health Canada Inspection Findings

Health CanadaInspected 2022-03-17 7 findingsEquipment and facilityDeviation, CAPA, and investigationStability and storageOther quality system

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

The maintenance of personnel records was inadequate. The ongoing training of personnel was inadequate.

2Equipment and facility

The establishment and/or the maintenance of a data governance plan was inadequate.

3Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate. The system for reviewing, revising, and approving standard operating procedures was inadequate.

4Equipment and facility

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.

5Stability and storage

The temperature and/or humidity control was inadequate.

6Stability and storage

The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.

7Other quality system

The implementation of a self-inspection program was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-03-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

MSS Ltd. findings history — including this company's other documents Health Canada documents, 2022 Go to Findings search